173 related articles for article (PubMed ID: 26110916)
1. GH-Releasing Hormone Promotes Survival and Prevents TNF-α-Induced Apoptosis and Atrophy in C2C12 Myotubes.
Gallo D; Gesmundo I; Trovato L; Pera G; Gargantini E; Minetto MA; Ghigo E; Granata R
Endocrinology; 2015 Sep; 156(9):3239-52. PubMed ID: 26110916
[TBL] [Abstract][Full Text] [Related]
2. GH-releasing hormone induces cardioprotection in isolated male rat heart via activation of RISK and SAFE pathways.
Penna C; Settanni F; Tullio F; Trovato L; Pagliaro P; Alloatti G; Ghigo E; Granata R
Endocrinology; 2013 Apr; 154(4):1624-35. PubMed ID: 23417421
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart.
Granata R; Trovato L; Gallo MP; Destefanis S; Settanni F; Scarlatti F; Brero A; Ramella R; Volante M; Isgaard J; Levi R; Papotti M; Alloatti G; Ghigo E
Cardiovasc Res; 2009 Jul; 83(2):303-12. PubMed ID: 19293247
[TBL] [Abstract][Full Text] [Related]
4. IGF-I does not prevent myotube atrophy caused by proinflammatory cytokines despite activation of Akt/Foxo and GSK-3beta pathways and inhibition of atrogin-1 mRNA.
Dehoux M; Gobier C; Lause P; Bertrand L; Ketelslegers JM; Thissen JP
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E145-50. PubMed ID: 16926385
[TBL] [Abstract][Full Text] [Related]
5. Agonists of growth hormone-releasing hormone stimulate self-renewal of cardiac stem cells and promote their survival.
Florea V; Majid SS; Kanashiro-Takeuchi RM; Cai RZ; Block NL; Schally AV; Hare JM; Rodrigues CO
Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17260-5. PubMed ID: 25404316
[TBL] [Abstract][Full Text] [Related]
6. Des-acyl ghrelin exhibits pro-anabolic and anti-catabolic effects on C2C12 myotubes exposed to cytokines and reduces burn-induced muscle proteolysis in rats.
Sheriff S; Kadeer N; Joshi R; Friend LA; James JH; Balasubramaniam A
Mol Cell Endocrinol; 2012 Apr; 351(2):286-95. PubMed ID: 22266196
[TBL] [Abstract][Full Text] [Related]
7. β-Hydroxy-β-methylbutyrate facilitates PI3K/Akt-dependent mammalian target of rapamycin and FoxO1/3a phosphorylations and alleviates tumor necrosis factor α/interferon γ-induced MuRF-1 expression in C2C12 cells.
Kimura K; Cheng XW; Inoue A; Hu L; Koike T; Kuzuya M
Nutr Res; 2014 Apr; 34(4):368-74. PubMed ID: 24774073
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor alpha (TNF-α) inactivates the PI3-kinase/PKB pathway and induces atrophy and apoptosis in L6 myotubes.
Sishi BJ; Engelbrecht AM
Cytokine; 2011 May; 54(2):173-84. PubMed ID: 21300557
[TBL] [Abstract][Full Text] [Related]
9. l-glutamine Improves Skeletal Muscle Cell Differentiation and Prevents Myotube Atrophy After Cytokine (TNF-α) Stress Via Reduced p38 MAPK Signal Transduction.
Girven M; Dugdale HF; Owens DJ; Hughes DC; Stewart CE; Sharples AP
J Cell Physiol; 2016 Dec; 231(12):2720-32. PubMed ID: 26991744
[TBL] [Abstract][Full Text] [Related]
10. Ginsenoside Rg3 upregulates myotube formation and mitochondrial function, thereby protecting myotube atrophy induced by tumor necrosis factor-alpha.
Lee SJ; Bae JH; Lee H; Lee H; Park J; Kang JS; Bae GU
J Ethnopharmacol; 2019 Oct; 242():112054. PubMed ID: 31271820
[TBL] [Abstract][Full Text] [Related]
11. The effect of a novel antagonist of growth hormone releasing hormone on cell proliferation and on the key cell signaling pathways in nine different breast cancer cell lines.
Pozsgai E; Schally AV; Hocsak E; Zarandi M; Rick F; Bellyei S
Int J Oncol; 2011 Oct; 39(4):1025-32. PubMed ID: 21701777
[TBL] [Abstract][Full Text] [Related]
12. Agonist of growth hormone-releasing hormone enhances retinal ganglion cell protection induced by macrophages after optic nerve injury.
Cen LP; Ng TK; Liang JJ; Xu C; Zhuang X; Liu YF; Chen SL; Xu Y; Yang Q; Yuan XL; Qin YJ; Chan SO; Chen H; Zhang M; Schally AV; Pang CP
Proc Natl Acad Sci U S A; 2021 Jul; 118(28):. PubMed ID: 34244423
[TBL] [Abstract][Full Text] [Related]
13. Impact of Axis of GHRH and GHRH Receptor on Cell Viability and Apoptosis of the Placental Choriocarcinoma Cell Line.
Liu AX; Zhang D; Zhu YM; Gao HJ; Jiang JY; Hu XL; Lv PP; Leung PC; Huang HF
Curr Mol Med; 2016; 16(3):299-311. PubMed ID: 26917260
[TBL] [Abstract][Full Text] [Related]
14. BST204, a Rg3 and Rh2 Enriched Ginseng Extract, Upregulates Myotube Formation and Mitochondrial Function in TNF-α-Induced Atrophic Myotubes.
Lee SJ; Im M; Park SK; Kim JY; So EY; Liang OD; Kang JS; Bae GU
Am J Chin Med; 2020; 48(3):631-650. PubMed ID: 32329640
[TBL] [Abstract][Full Text] [Related]
15. TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine.
Dogra C; Changotra H; Wedhas N; Qin X; Wergedal JE; Kumar A
FASEB J; 2007 Jun; 21(8):1857-69. PubMed ID: 17314137
[TBL] [Abstract][Full Text] [Related]
16. Calpain activation causes a proteasome-dependent increase in protein degradation and inhibits the Akt signalling pathway in rat diaphragm muscle.
Smith IJ; Dodd SL
Exp Physiol; 2007 May; 92(3):561-73. PubMed ID: 17272355
[TBL] [Abstract][Full Text] [Related]
17. S-allyl cysteine inhibits TNFα-induced skeletal muscle wasting through suppressing proteolysis and expression of inflammatory molecules.
Dutt V; Saini V; Gupta P; Kaur N; Bala M; Gujar R; Grewal A; Gupta S; Dua A; Mittal A
Biochim Biophys Acta Gen Subj; 2018 Apr; 1862(4):895-906. PubMed ID: 29288771
[TBL] [Abstract][Full Text] [Related]
18. Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy.
Léger B; Cartoni R; Praz M; Lamon S; Dériaz O; Crettenand A; Gobelet C; Rohmer P; Konzelmann M; Luthi F; Russell AP
J Physiol; 2006 Nov; 576(Pt 3):923-33. PubMed ID: 16916907
[TBL] [Abstract][Full Text] [Related]
19. Protective Effect of
Lee MK; Choi JW; Choi YH; Nam TJ
Mar Drugs; 2019 May; 17(5):. PubMed ID: 31083497
[TBL] [Abstract][Full Text] [Related]
20. AMP-activated protein kinase enhances the expression of muscle-specific ubiquitin ligases despite its activation of IGF-1/Akt signaling in C2C12 myotubes.
Tong JF; Yan X; Zhu MJ; Du M
J Cell Biochem; 2009 Oct; 108(2):458-68. PubMed ID: 19639604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
